Manipal Health Enterprises IPO is a book-built mainboard IPO that aims to raise approximately ₹9,275.22 crore through a combination of a fresh issue and an Offer for Sale (OFS). The IPO includes a fresh issue of around ₹7,998 crore and an OFS component of ₹1,275.22 crore by existing shareholders.
The IPO is scheduled to open for subscription on 29 July 2026 and close on 31 July 2026. The company has fixed the price band at ₹560–₹590 per share, with shares proposed to be listed on both the BSE and NSE. The minimum application size is 25 shares, requiring a minimum investment of ₹14,750 at the upper price band.
Manipal Health Enterprises IPO: Key Details
Here is a quick overview of the Manipal Health Enterprises IPO:
Particulars
Details
IPO Type
Book-built Mainboard IPO
IPO Size
₹9,275.22 Crore
Fresh Issue
₹7,998 Crore (Approx.)
Offer for Sale
₹1,275.22 Crore
Price Band
₹560 – ₹590 per Share
Face Value
₹2 per Share
Lot Size
25 Shares
Minimum Investment
₹14,750
IPO Opens
29 July 2026
IPO Closes
31 July 2026
Allotment Date
3 August 2026
Listing Date
5 August 2026
Listing Exchange
BSE & NSE
Issue Type
Fresh Issue + OFS
Note: Grey Market Premium (GMP) changes frequently based on market conditions and should not be considered the only factor while making an investment decision.
For complete information about the company, financial performance, IPO timeline, subscription details, and other updates, check the detailed Manipal Health Enterprises Limited IPO page.
About Manipal Health Enterprises Limited
Manipal Health Enterprises Limited operates the Manipal Hospitals network and is one of India's leading private healthcare providers. The company runs a large multispecialty hospital network across India, providing tertiary and quaternary healthcare services.
As of March 2026, the company operates 49 hospitals with over 13,000 licensed beds across multiple states and union territories. Its healthcare services cover several specialties, including cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal care.
The company serves millions of patients annually and has built a strong presence through organic expansion and acquisitions of healthcare assets. Its network includes hospitals across major cities, allowing it to cater to growing demand for quality healthcare services in India.
Manipal Health Enterprises IPO Structure
The IPO consists of both a Fresh Issue and an Offer for Sale (OFS).
Through the fresh issue component, the company will raise new capital that will be used for business objectives, including strengthening its balance sheet and supporting strategic initiatives. A portion of the IPO proceeds is planned towards repayment or prepayment of borrowings and acquisition-related requirements.
The OFS component allows existing shareholders to sell part of their holdings. The proceeds from the OFS will go directly to the selling shareholders rather than the company.
Strong Business Growth and Financial Performance
Manipal Health Enterprises has shown strong growth in revenue and profitability, supported by expansion of its hospital network and increasing demand for healthcare services.
Financial Highlights
Particulars (₹ Crore)
FY24
FY25
FY26
Revenue from Operations
6,171.63
8,242.25
10,335.75
EBITDA
1,776.60
2,247.07
2,795.94
Profit After Tax
533.2
1,081.67
916.52
Between FY24 and FY26:
Revenue increased significantly, reflecting expansion of the hospital network.
EBITDA improved with higher operational scale.
Profitability remained strong despite integration costs and expansion-related activities.
The company continued investing in healthcare infrastructure and capacity expansion.
IPO Objects
The company plans to utilise the IPO proceeds for:
Repayment or prepayment of borrowings of subsidiaries.
Funding strategic acquisitions and healthcare expansion plans.
General corporate purposes.
A significant portion of the fresh issue proceeds is expected to support balance sheet strengthening after expansion and acquisition activities.
Risks Investors Should Know
Every IPO comes with certain risks, and Manipal Health Enterprises IPO also has some factors investors should evaluate:
The healthcare industry is highly competitive, with pressure from both large hospital chains and regional players.
Expansion through acquisitions may involve integration challenges.
High capital requirements in the hospital business can impact profitability.
The company operates in a regulated sector where policy changes may affect operations.
Increased debt due to expansion activities remains an important factor for investors to monitor.
Investors should carefully review the Red Herring Prospectus (RHP) before making any investment decision.
Three Important IPO Facts
Before investing, keep these points in mind:
Manipal Health Enterprises IPO is one of the largest healthcare IPOs in India, with an issue size of over ₹9,000 crore.
The company operates a large hospital network with 49 hospitals and more than 13,000 licensed beds across India.
The IPO proceeds will support financial strengthening, acquisitions, and future expansion of healthcare infrastructure.
Summary
Manipal Health Enterprises Limited has established itself as one of India's leading private healthcare providers with a strong hospital network, diversified medical specialties, and expanding healthcare infrastructure.
The company has demonstrated consistent revenue growth and operational improvement, supported by increasing demand for quality healthcare services. The IPO provides investors an opportunity to participate in India's growing healthcare sector.
However, investors should consider factors such as valuation, debt levels, acquisition strategy, competitive landscape, and future growth plans before making an investment decision. As with any IPO investment, investors should carefully analyse company fundamentals, financial performance, industry outlook, and the Red Herring Prospectus (RHP) before subscribing.
Disclaimer: This article is intended solely for informational and educational purposes and should not be treated as investment advice. IPO details, subscription figures, GMP, and market information are subject to change. Investors should refer to official documents and consult a qualified financial advisor before making investment decisions.
Author: Diwakar Kumar Singh
Diwakar Kumar Singh is a BFSI specialist and finance writer with over 7 years of hands-on experience in financial research, content creation, and analysis.
A Gold Medalist in MBA (Marketing) from IMT, he combines deep analytical skills with practical insights gained from evaluating companies, IPOs, unlisted shares, financial ratios, and investment opportunities. Diwakar has personally analysed hundreds of financial instruments and market scenarios, which he uses to break down complex topics into clear, actionable advice.
He has authored numerous in-depth finance articles, published multiple books internationally, and contributed to research publications. His work focuses on helping everyday investors and readers make better-informed financial decisions through well-researched, evidence-based explanations that are always grounded in real-world application rather than theory alone.
care@investkraft.com
+91-9599071040
+91-9797971876
